1. Effects of Perioperative Inflammatory Response in Cervical Cancer: Laparoscopic versus Open Surgery
   Ji-Hoon Sim et al, 2021, Journal of Clinical Medicine CrossRef
2. Associations between early changes in the neutrophil-to-lymphocyte ratio after radical nephroureterectomy and treatment outcomes
   Shun Saito et al, 2024, Japanese Journal of Clinical Oncology CrossRef
3. Update on perioperative management of patients undergoing surgery for liver cancer
   Masaki Kaibori et al, 2022, Annals of Gastroenterological Surgery CrossRef
4. Association between early change in neutrophil‐to‐lymphocyte ratio after radical cystectomy and treatment outcomes
   Haim Herzberg et al, 2022, BJU International CrossRef
5. Immunotherapy Using Activated Natural Killer Cells Improves Postoperative Neutrophil-to-Lymphocyte Ratio and Long-Term Prognosis of Living Donor Liver Transplant Recipients With Hepatocellular Carcinoma
   Kouki Imaoka et al, 2024, Transplantation Proceedings CrossRef
6. Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
   Shuofeng Li et al, 2023, Technology in Cancer Research & Treatment CrossRef
7. The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma
   Yoshiyuki Matsui et al, 2022, International Journal of Clinical Oncology CrossRef
8. Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma
   Hironori Ochi et al, 2023, Hepatology Research CrossRef
9. Combining Preoperative and Postoperative Inflammatory Indicators Can Better Predict the Recurrence of Hepatocellular Carcinoma After Partial Hepatectomy
   Meilong Wu et al, 2021, Journal of Inflammation Research CrossRef
10. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review
    Kian Heshmat-Ghahdarijani et al, 2023, Frontiers in Oncology CrossRef
11. A Combination of Blood Lymphocytes and AST Levels Distinguishes Patients with Small Hepatocellular Carcinomas from Non-cancer Patients
    Brian I. Carr et al, 2021, Journal of Gastrointestinal Cancer CrossRef